Literature DB >> 19845683

Mediators and receptors in the resolution of inflammation: drug targeting opportunities.

A G Stewart.   

Abstract

The active resolution of inflammation is recognized as offering new opportunities to generate novel anti-inflammatory agents. The emerging appreciation of the importance of active resolution in regulation of inflammation also creates an imperative to examine developing and existing agents for their potential to influence these pathways. This themed issue of the British Journal of Pharmacology contains papers that discuss the roles of annexin-1, lipoxins and related lipid products of fish oils as well as other mechanisms involved in active resolution and their receptor targets.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19845683      PMCID： PMC2785516          DOI： 10.1111/j.1476-5381.2009.00484.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  20 in total

Review 1.  Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.

Authors:  C N Serhan; N Chiang
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 2.  Principles of safety pharmacology.

Authors:  M K Pugsley; S Authier; M J Curtis
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

Review 3.  Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.

Authors:  Mauro Perretti; Jesmond Dalli
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

Review 4.  Lipoxins: resolutionary road.

Authors:  Paola Maderna; Catherine Godson
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

5.  Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles.

Authors:  Amy Jo Galliher-Beckley; Jason Grant Williams; Jennifer Brady Collins; John Anthony Cidlowski
Journal:  Mol Cell Biol       Date:  2008-10-06       Impact factor: 4.272

Review 6.  Annexin-A1: a pivotal regulator of the innate and adaptive immune systems.

Authors:  F D'Acquisto; M Perretti; R J Flower
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

Review 7.  Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.

Authors:  Heike Schäcke; Markus Berger; Hartmut Rehwinkel; Khusru Asadullah
Journal:  Mol Cell Endocrinol       Date:  2007-05-31       Impact factor: 4.102

Review 8.  Glucocorticoids: exemplars of multi-tasking.

Authors:  Julia C Buckingham
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

9.  Anesthetics impact the resolution of inflammation.

Authors:  Nan Chiang; Jan M Schwab; Gabrielle Fredman; Kie Kasuga; Simon Gelman; Charles N Serhan
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

Review 10.  Translational systems biology of inflammation.

Authors:  Yoram Vodovotz; Marie Csete; John Bartels; Steven Chang; Gary An
Journal:  PLoS Comput Biol       Date:  2008-04-25       Impact factor: 4.475
View more
  3 in total

1.  Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome.

Authors:  Eylem Karatay; Özlem Gül Utku
Journal:  Turk J Gastroenterol       Date:  2020-02       Impact factor: 1.852

2.  CD300a contributes to the resolution of articular inflammation triggered by MSU crystals by controlling neutrophil apoptosis.

Authors:  Bruno V S Valiate; Celso M Queiroz-Junior; Francesca Levi-Schaffer; Izabela Galvão; Mauro M Teixeira
Journal:  Immunology       Date:  2021-06-06       Impact factor: 7.215

3.  Evaluation of the anti-inflammatory effects of synthesised tanshinone I and isotanshinone I analogues in zebrafish.

Authors:  Matthew J Foulkes; Faith H Tolliday; Katherine M Henry; Stephen A Renshaw; Simon Jones
Journal:  PLoS One       Date:  2020-10-06       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.